Respiratory syncytial virus infection in infants with heart and lung diseases

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Respiratory syncytial virus (RSV) is a major causative agent of respiratory infection in infants because of its affinity for bronchial and alveolar epithelial cells. Serious and sometimes fatal RSV infection may develop in premature infants as well as infants with chronic lung disease and congenital heart disease (CHD). In infants with CHD, the addition of RSV infection to the underlying respiratory pathology resulting from increase or decrease in pulmonary blood flow may cause significant problems such as serious symptoms, increases in hospitalization rate, postponement of elective heart surgery, or death. Strict infection control measures with administration of anti-RSV antibody are essential in the management of infants with heart and lung diseases.

Original languageEnglish
Title of host publicationMolecular Mechanism of Congenital Heart Disease and Pulmonary Hypertension
PublisherSpringer Singapore
Pages215-220
Number of pages6
ISBN (Electronic)9789811511851
ISBN (Print)9789811511844
DOIs
Publication statusPublished - 2020 Jan 1

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Respiratory syncytial virus infection in infants with heart and lung diseases'. Together they form a unique fingerprint.

  • Cite this

    Yamagishi, H. (2020). Respiratory syncytial virus infection in infants with heart and lung diseases. In Molecular Mechanism of Congenital Heart Disease and Pulmonary Hypertension (pp. 215-220). Springer Singapore. https://doi.org/10.1007/978-981-15-1185-1_31